Ecolab stock: higher guidance still leaves little room at 38 times earnings
ECL stock analysis and fair value · bull and bear case
The call: SageNoodle rates Ecolab Fairly Valued: base-case fair value USD 245 against a price of USD 282, 13% below the quote on a 3–5 years horizon. The latest substantive development is Ecolab’s July 28, 2026 second-quarter report and modestly higher full-year adjusted EPS outlook, not a disclosed event on October 7.
Ecolab stock has a fresh earnings catalyst: management raised its 2026 adjusted EPS outlook after organic growth accelerated. Stronger execution helps, yet the current valuation already prices in much of the improvement.

Valuation as of 7 Oct 2026 · Quote currency: USD. Latest quote: Fri, 09 Oct 2026 18:31:15 GMT.
Written with AI from the linked sources and reviewed by a SageNoodle editor. How we work.
Latest quote
USD 281.81
At publication
USD 280.82
Fair value
USD 244.50
Upside
-13.2%
P/E at publication
37.7x
EV/EBITDA
Not available
FCF yield
0.0%
ROIC Not available · Horizon 3–5 years
Why Ecolab (ECL) stock is mispriced
- 01
The latest substantive development is Ecolab’s July 28, 2026 second-quarter report and modestly higher full-year adjusted EPS outlook, not a disclosed event on October 7.
- 02
Underlying growth and pricing are improving, but a 37.7x trailing P/E and 2.4% trailing free-cash-flow yield leave the share price dependent on continued growth and successful acquisition integration.
- 03
Our probability-weighted scenario value is about $244 per share, below the $280.82 share price; near-term execution may improve earnings without removing valuation risk.
What Ecolab does and how it makes money
Ecolab Inc. (NYSE: ECL) sells water, hygiene and infection-prevention products and services to commercial and industrial customers. Its business combines products and equipment with recurring service and lease sales, including water treatment, institutional cleaning, pest elimination and life-sciences solutions. The company reports Global Water, Global Institutional & Specialty, Global Pest Elimination and Global Life Sciences segments. Its customers span food, hospitality, healthcare, manufacturing, data centers and pharmaceutical production; it serves markets in more than 170 countries, according to the company’s July 28, 2026 second-quarter earnings release.
For the financial history and all coverage, see ECOLAB INC. (ECL) company research.
What actually happened to Ecolab stock today?
Ecolab shares are reported up 1.4% on October 7, 2026, at $280.82. No company announcement or other event has been identified that explains that move. There are no fresh headlines in the last-day feed, and low social-media mention volume cannot establish a cause. The latest disclosed operating catalyst is older: Ecolab’s second-quarter results and outlook update, released July 28, 2026.
The company reported second-quarter sales of $4.4 billion, up 10%, while organic sales growth accelerated to 5%. Adjusted diluted EPS was $2.09, up 11%, and management raised its full-year 2026 adjusted EPS range to $8.05–$8.25 from $8.03–$8.23. The report is a positive business update, but it does not explain today’s trading. Ecolab’s Q2 2026 earnings release
Pricing is catching up with costs, with one important qualification
The useful detail is how Ecolab got the quarter through a cost squeeze. Management said reported volume grew 1% despite a nearly 1% headwind from Middle East customer disruptions; pricing improved to 4%, helped by energy surcharges. Ecolab said the pricing and productivity more than offset rising commodity costs. That matters because price increases protect profit only if customers keep buying and the added charge catches up with input inflation.
There is evidence of a lag, not a clean victory. Reported operating income rose 7%, while adjusted diluted EPS rose 11%; adjusted gross margin fell 60 basis points because of the Ovivo Electronics acquisition. Excluding that acquisition’s impact, the company said organic gross margin was stable. The distinction matters: the underlying pricing story looks better, but acquisition accounting and costs complicate the headline margin picture. These are management’s reported results and explanations, not independent proof that the margin pressure is over. Ecolab’s Q2 2026 earnings release
Growth engines are gaining weight, and debt is part of the bill
Global High-Tech grew 29% organically in the quarter and Life Sciences 15%, according to Ecolab. Those businesses broaden the growth story beyond established cleaning and water-treatment operations. Management says the Global High-Tech platform is approaching $1.5 billion in annualized sales and targets $4 billion by 2030, with 25% operating margins. That is a plan, not delivered revenue. The target deserves credit only as these sales arrive and earn the promised margins.
The acquisition strategy also raises the financing cost of the bet. Ecolab said second-quarter net interest expense increased $10 million, reflecting lower cash balances and new debt used to fund recent acquisitions. The June 30 balance sheet reported $5.1 billion of cash and $13.2 billion of short- and long-term debt. The market is being asked to pay for growth engines while the company integrates acquisitions and services a larger debt load. Ecolab’s Q2 2026 earnings release
At 37.7 times trailing earnings, execution has to stay on schedule
At $280.82, Ecolab has a trailing P/E of 37.7x and trailing free-cash-flow yield of 2.4%. Those are demanding terms for a business whose FY2025 revenue grew 2.2%, even with its attractive recurring services and current improvement in organic growth. The valuation requires investors to believe that pricing, productivity and faster-growing niches can sustain better earnings growth.
Our valuation uses a direct earnings-multiple method. Assumptions: bear case $7.60 adjusted EPS at 25x, or $190 per share; base case $8.15, the midpoint of management’s 2026 guide, at 30x, or $244.50; bull case $8.50 at 35x, or $297.50. Applying 25%, 50% and 25% probabilities gives approximately $244 per share. These multiples are analyst assumptions, not company guidance. On that estimate, shares look somewhat expensive, though not enough below fair value to meet our 15% overvaluation threshold.
The long-term thesis is intact but not strengthened by today’s unexplained move. The next useful test is the third-quarter report: management expects adjusted EPS of $2.13–$2.23, with second-half organic sales growth of 6%–7% and adjusted operating margin of about 19%. Watch whether pricing supports margins as promised, whether volumes continue to grow, and whether acquisition-driven interest and amortization costs ease. A miss on those operating measures would challenge the earnings premium; a share-price uptick alone does not. Ecolab’s Q2 2026 earnings release
Follow SageNoodle on Google
Ecolab revenue, margins and cash flow
Revenue (USD, billions)
Margins (%)
Free cash flow (USD, billions)
Estimated ROIC (%)
Net debt (USD, billions)
Monetary values are in USD; revenue, FCF and net debt are in billions; EPS is per share. Missing values appear as gaps and “Not available.” Source: SEC EDGAR XBRL filings, latest restated values; quarterly cash flow derived from year-to-date figures; Q4 = fiscal year minus nine months. ROIC is NOPAT (21% tax) over debt plus equity.
| Period | Revenue | Gross % | Op % | FCF | EPS | ROIC % | Net debt |
|---|---|---|---|---|---|---|---|
| FY2016 | 13.2 | Not available | 14.2 | 1.18 | 4.14 | Not available | Not available |
| FY2017 | 11.5 | Not available | 15.2 | 1.30 | 5.12 | Not available | Not available |
| FY2018 | 12.2 | Not available | 14.1 | 1.50 | 4.88 | Not available | Not available |
| FY2019 | 12.6 | Not available | 14.7 | 1.69 | 5.33 | Not available | Not available |
| FY2020 | 11.8 | Not available | 11.8 | 1.37 | -4.15 | Not available | Not available |
| FY2021 | 12.7 | Not available | 12.6 | 1.42 | 3.91 | Not available | Not available |
| FY2022 | 14.2 | Not available | 11.0 | 1.08 | 3.81 | Not available | Not available |
| FY2023 | 15.3 | Not available | 13.0 | 1.64 | 4.79 | Not available | Not available |
| FY2024 | 15.7 | Not available | 17.8 | 1.82 | 7.37 | Not available | Not available |
| FY2025 | 16.1 | Not available | 17.0 | 1.90 | 7.28 | Not available | Not available |
What Ecolab management has said
Guidance
Paraphrased commentary
Management raised its 2026 adjusted diluted EPS outlook to $8.05–$8.25, citing strong underlying performance and near-term CoolIT amortization and financing costs.
Margins
Paraphrased commentary
The company said pricing and productivity more than offset higher commodity costs, while adjusted gross margin was affected by the Ovivo Electronics acquisition.
Ecolab fair value: bear, base and bull scenarios
Dot marks the latest quote of USD 281.81.
Bear
25%USD 190
Direct equity valuation: assumed adjusted EPS multiplied by assumed P/E multiple.
Equity value USD 53.62B ÷ 0.282B diluted shares
- Adjusted EPS
- $7.60, analyst assumption
- P/E multiple
- 25x, analyst assumption
- Calculation
- $7.60 × 25 = $190 per share
Growth and pricing underdeliver while acquisition and financing costs persist; the market assigns a lower multiple.
Base
50%USD 245
Direct equity valuation: assumed adjusted EPS multiplied by assumed P/E multiple.
Equity value USD 69.00B ÷ 0.282B diluted shares
- Adjusted EPS
- $8.15, midpoint of company’s 2026 guide
- P/E multiple
- 30x, analyst assumption
- Calculation
- $8.15 × 30 = $244.50 per share
The company delivers around the midpoint of its adjusted EPS guidance, with growth continuing but the premium multiple moderating.
Bull
25%USD 298
Direct equity valuation: assumed adjusted EPS multiplied by assumed P/E multiple.
Equity value USD 83.95B ÷ 0.282B diluted shares
- Adjusted EPS
- $8.50, analyst assumption above company guide
- P/E multiple
- 35x, analyst assumption
- Calculation
- $8.50 × 35 = $297.50 per share
Pricing holds, growth engines scale quickly and investors continue to award a premium multiple.
Ecolab (ECL) stock: bullish vs bearish case
Bull case
- Organic growth accelerated to 5% in Q2, and management raised its full-year adjusted EPS outlook.
- Pricing improved to 4% while Ecolab said productivity helped offset higher commodity costs.
- High-Tech and Life Sciences grew organically by 29% and 15%, respectively, in Q2.
Bear case
- The 37.7x trailing P/E and 2.4% trailing free-cash-flow yield leave limited valuation cushion.
- Second-quarter net interest expense rose as debt funded acquisitions; integration and financing costs may weigh on earnings.
- The Global High-Tech $4 billion sales target for 2030 is management’s forecast, not achieved performance.
Ecolab stock risks
| Risk | Severity | Probability | Rationale |
|---|---|---|---|
| Premium valuation | High | Medium | The share price implies strong continuation of earnings growth; a lower multiple could reduce value even if the business remains healthy. |
| Acquisition integration and leverage | Medium | Medium | Recent acquisitions have added amortization and financing costs, and management attributes higher interest expense partly to acquisition funding. |
| Pricing, commodity and customer disruption | Medium | Medium | Commodity inflation and Middle East customer disruptions remain business pressures; the pricing response must preserve volume and margins. |
Ecolab catalysts: what could move ECL stock
- 2026 Q3 results; date not suppliedNeutral
Third-quarter earnings and margin update
Management expects adjusted diluted EPS of $2.13–$2.23 and says organic operating income growth should improve in key segments. Results will test its pricing and margin outlook.
Ecolab fair value history
| Period | Fair value | Verdict | Note |
|---|
Ecolab news
Ecolab stock: common questions
- Is Ecolab (ECL) stock undervalued or overvalued?
- SageNoodle rates Ecolab Fairly Valued: base-case fair value USD 245 against a price of USD 282, 13% below the quote on a 3–5 years horizon. The latest substantive development is Ecolab’s July 28, 2026 second-quarter report and modestly higher full-year adjusted EPS outlook, not a disclosed event on October 7.
- What is Ecolab's fair value?
- Bear USD 190 (25% probability, Direct equity valuation: assumed adjusted EPS multiplied by assumed P/E multiple.); Base USD 245 (50% probability, Direct equity valuation: assumed adjusted EPS multiplied by assumed P/E multiple.); Bull USD 298 (25% probability, Direct equity valuation: assumed adjusted EPS multiplied by assumed P/E multiple.). The company delivers around the midpoint of its adjusted EPS guidance, with growth continuing but the premium multiple moderating.
- What is the bull case for ECL stock?
- Organic growth accelerated to 5% in Q2, and management raised its full-year adjusted EPS outlook. Pricing improved to 4% while Ecolab said productivity helped offset higher commodity costs. High-Tech and Life Sciences grew organically by 29% and 15%, respectively, in Q2.
- What is the bear case for ECL stock?
- The 37.7x trailing P/E and 2.4% trailing free-cash-flow yield leave limited valuation cushion. Second-quarter net interest expense rose as debt funded acquisitions; integration and financing costs may weigh on earnings. The Global High-Tech $4 billion sales target for 2030 is management’s forecast, not achieved performance.
- What are the biggest risks to Ecolab stock?
- Premium valuation (High severity): The share price implies strong continuation of earnings growth; a lower multiple could reduce value even if the business remains healthy. Acquisition integration and leverage (Medium severity): Recent acquisitions have added amortization and financing costs, and management attributes higher interest expense partly to acquisition funding. Pricing, commodity and customer disruption (Medium severity): Commodity inflation and Middle East customer disruptions remain business pressures; the pricing response must preserve volume and margins.
- What could move ECL stock next?
- 2026 Q3 results; date not supplied: Third-quarter earnings and margin update. Management expects adjusted diluted EPS of $2.13–$2.23 and says organic operating income growth should improve in key segments. Results will test its pricing and margin outlook.
Company reference pages
Browse company filings and market quotes to check the latest information. These pages update over time and are separate from the documents cited in this report.